Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Jensen Huangs admitted affair with a woman suspected by U.S. authorities of being a Chinese spyand Nvidias board investigationhas fueled concern about leadership, national-security scrutiny and potential fallout for the company. Traders are divided between fearing a prolonged selloff or Huangs departure and viewing the reaction as overblown, with many buying the dip on the view that Nvidias AI-chip business remains intact.

Hims & Hers is under pressure after its quarterly report showed an unexpected loss, margin compression and a reduced profit outlook, despite strong revenue growth; traders also point to a sequential subscriber decline. Some investors see the planned Peptides+ launch and Andrew Hubermans board role as potential growth drivers, while skeptics question whether those initiatives can offset profitability and execution concerns.

Digital Turbines earnings beat and higher revenue outlook were followed by a sharp selloff as traders focused on gross-margin compression, unchanged profit guidance, and debt concerns. The community is split between viewing the drop as an overreaction to a growing business and seeing margins and profitability as real risks.

MARAs quarterly results and earnings call have traders weighing debt reduction, a share-repurchase authorization and a GPU-services contract against a revenue miss and the lack of larger AI data-center tenant leases. Some see the contract and balance-sheet moves as progress beyond Bitcoin mining, while skeptics question execution and remain concerned about the companys exposure to Bitcoins swings.

Trade Desks quarterly results beat expectations and its next-quarter outlook was stronger, but the post-earnings surge quickly faded as traders focused on declining year-over-year revenue, temporary revenue tailwinds and managements cautious tone. Bulls point to the buyback authorization and potential short squeeze, while skeptics question whether the business has returned to sustainable growth and note that the company had not recently repurchased shares.

GTA VIs approaching launch and managements report of exceptionally strong preorders are driving attention, with traders betting on blockbuster sales and a boost to Take-Twos business. Others argue the launch may already be priced in and point to weaker bookings and unchanged guidance, raising sell-the-news and recurring-revenue concerns.

SITC data from Candels PrTK05 prostate-cancer study showing immune activation and transient vector detection are being viewed by bullish traders as supportive of the planned BLA for aglatimagene. Others remain concerned about the filing timeline, manufacturing readiness, and managements transparency, while the share-price weakness has tempered enthusiasm.

A volatile rebound and perceived resilience while broader crypto markets are weak are driving attention to PEPE. Bulls see renewed meme-coin momentum, while skeptics point to past rallies fading and question whether the move can hold.

Senseonics Q3 results, marked by sharply higher revenue and raised full-year guidance, are driving attention and a sharp rally. Many traders welcome the commercial progress, while others question whether it can offset ongoing losses and cash needs, and warn that gains may not hold.

TG Therapeutics strong Q3 results and raised full-year revenue outlook, driven by continued BRIUMVI growth, are the main focus; traders also discussed a sharp earnings-related dip followed by a recovery. Attention is shifting to the anticipated subcutaneous BRIUMVI Phase 3 readout, while buyout and short-squeeze talk remains speculative.